Wednesday, August 17, 2022
wellness India Expo
Home Tags Bharat Biotech

Tag: Bharat Biotech

Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene partnership with Bharat Biotech &...

An entirely new “chimeric” spike antigen complex, different from any protein of existing SARS-CoV-2 variants, will be generated

Bharat Biotech’s Covaxin gets emergency approval for 6-12 age group

Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study in children 2-18 years of age

USFDA declines EUA nod to Covaxin

Despite receiving emergency use listing from the World Health Organization, Covaxin has not been cleared for any age group in the United States

BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic

Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India

Bharat Biotech gets DCGI nod for Phase 3 clinical trials of...

The trials for 0.5 ml single dose of nasal vaccine will be conducted at nine locations in the country.

Biotech stalwarts to be honored with Padma Bhushan Award

Dr Cyrus Poonawalla of Serum Institute of India; and Dr Krishna Ella and Suchitra Ella of Bharat Biotech have found their place in the just released list of Padma Awards. They will be honored with Padma Bhushan for the role played by their companies during Covid-19 pandemic

CSIR-IMTECH celebrates its 38th Foundation Day

Dr. Krishna Ella, Chairman & Managing Director of Bharat Biotech International Limited delivered this year’s Foundation Day Lecture virtually on ‘Innovation and Leadership in Pandemic’

COVAXIN (BBV152) booster shown to neutralize both Omicron & Delta variants...

100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization of the Omicron variant

COVAXIN booster dose study shows promising results

The phase 2, double-blind, randomised controlled COVAXIN trial demonstrated long-term safety with no serious adverse events

COVAXIN approval for kids: India to vaccinate children aged 15-18 years...

As a precautionary measure, the healthcare workers and doctors will be given additional Covid-19 vaccine doses from January 10, 2022. Also, the people with co-morbidities and 60 years of age will get booster doses